Click Here for 5% Off Your First Aladdin Purchase!

Ragifilimab (anti-TNFRSF18) - Primary antibody, specific to TNFRSF18, >95%, high purity, Human IgG1, AGONIST of Tumor necrosis factor receptor superfamily member 18 agonist

  • Azide Free
  • Carrier Free
  • ExactAb™
  • Low Endotoxin
  • Recombinant
  • Validated
  • ≥95%(SDS-PAGE&SEC)
  • Lot by Lot
Features and benefits
  • Short Overview:

    Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

  • Species reactivity(Reacts with): Cynomolgus monkey,Human
  • Isotype: Human IgG1
    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
Item Number
Ab176088
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab176088-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$39.90
Ab176088-1mg
1mg
In stock
$169.90
Ab176088-5mg
5mg
In stock
$399.90
Ab176088-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$659.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product NameRagifilimab (anti-TNFRSF18) - Primary antibody, specific to TNFRSF18, >95%, high purity, Human IgG1
SynonymsActivation inducible TNFR family receptor antibody; Activation-inducible TNFR family receptor antibody; AITR antibody; CD357 antibody; GITR antibody; GITR D antibody; GITR-D antibody; GITRD antibody; Glucocorticoid induced TNFR related protein antibody; g
Specifications & PurityExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
SpecificityTNFRSF18
ConjugationUnconjugated
GradeAzide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action TypeAGONIST
Mechanism of actionAGONIST of Tumor necrosis factor receptor superfamily member 18 agonist
Product Description

Ragifilimab (anti-TNFRSF18) is an agonist monoclonal antibody targeting the glucocorticoid-induced TNFR-related protein (GITR). Ragifilimab (anti-TNFRSF18) can be used for advanced or metastatic solid tumors research.
Purity
>95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg

Product Properties

IsotypeHuman IgG1
Light Chain Typekappa
SDS-PAGE27.8 kDa (Light Chain) & 51.5 kDa (Heavy Chain), under reducing conditions; 176.3 kDa, under non-reducing conditions.
Purification MethodProtein A purified
Purity>95%
FormLiquid
ConcentrationLot by Lot
Storage TempStore at -80°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS2207590-51-8

Images

Ragifilimab (anti-TNFRSF18) (Ab176088) - Flow Cytometry
Flow Cytometry analysis of PHA-stimulated (3 days) human peripheral blood lymphocytes labelling TNFRSF18 with Ragifilimab (anti-TNFRSF18) (Ab176088) conjugated with biotin (right panel) compared with Human IgG (Ab170213) conjugated with biotin - Isotype Control (left panel) and detected with SA-PE (rp156250).

Ragifilimab (anti-TNFRSF18) (Ab176088) - Flow Cytometry
Flow Cytometry analysis of PHA-stimulated (3 days) human peripheral blood lymphocytes labelling TNFRSF18 (red) with Ragifilimab (anti-TNFRSF18) (Ab176088) conjugated with biotin and detected with SA-PE (rp156250). Blue - Isotype control, human IgG (Ab170213) conjugated with biotin. Black - Unlabelled control, cells without incubation with primary antibody.

Ragifilimab (anti-TNFRSF18) (Ab176088) - SEC
The purity of Ragifilimab (anti-TNFRSF18) (Ab176088) is more than 95% verified by HPLC.

Associated Targets

TNFRSF18 Tbio Tumor necrosis factor receptor superfamily member 18 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

2 results found

Lot NumberCertificate TypeDateItem
ZJ23F1101574Certificate of AnalysisNov 08, 2023 Ab176088
ZJ23F1101557Certificate of AnalysisNov 08, 2023 Ab176088

Related Documents

References

1. Kwon, B B and 9 more authors..  (1999)  Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand..  The Journal of biological chemistry,    (5):   [PMID:10037686]
2. Gurney, A L AL and 15 more authors..  (1999)  Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR..  Current biology : CB,    (25):   [PMID:10074428]
3. Nocentini, G G and 7 more authors..  (2000)  Identification of three novel mRNA splice variants of GITR..  Cell death and differentiation,      [PMID:10836847]

Solution Calculators